The following data is part of a premarket notification filed by Quidel Corporation with the FDA for Solana Influenza A+b Assay.
| Device ID | K161814 |
| 510k Number | K161814 |
| Device Name: | Solana Influenza A+B Assay |
| Classification | Respiratory Virus Panel Nucleic Acid Assay System |
| Applicant | Quidel Corporation 2005 East State Street, Suite 100 Athens, OH 45701 |
| Contact | Ronald H. Lollar |
| Correspondent | Ronald H. Lollar Quidel Corporation 2005 East State Street, Suite 100 Athens, OH 45701 |
| Product Code | OCC |
| Subsequent Product Code | OOI |
| Subsequent Product Code | OZE |
| CFR Regulation Number | 866.3980 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2016-07-01 |
| Decision Date | 2016-09-27 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 30014613336068 | K161814 | 000 |